Target intelligence / Profile preview

CDH8 antisense RNA 1 (CDH8-AS1)

Target
CDH8-AS1
Molecular classification
Long non-coding RNA
01

Overview

CDH8 antisense RNA 1 (CDH8-AS1) is presumed to be a long non-coding RNA transcript that is transcribed antisense to the CDH8 gene. Long non-coding RNAs (lncRNAs), in general, are RNA molecules longer than 200 nucleotides that do not code for proteins but can have regulatory functions in gene expression. However, there is very limited, if any, peer-reviewed literature or curated database evidence describing the specific function, molecular classification, disease relevance, or drug interactions of CDH8-AS1. Most available information about the region concerns CDH8, a cadherin family protein involved in cell adhesion during development. The term CDH8-AS1 may be referenced in some genomic databases as a predicted or uncharacterized lncRNA, but as of now, it is not established as a therapeutic target, biomarker, or disease-associated molecule in publicly available scientific literature. If your intent was to refer to the well-characterized CHD8 (chromodomain helicase DNA binding protein 8), there are abundant data linking it to neurodevelopment, autism, chromatin remodeling, and gene regulation[1][2][3][4][5]. However, "CDH8-AS1" specifically appears to be either: - Not a well-characterized entity in scientific literature, - Or, potentially misspelled or confused with "CHD8" or "CDH8". Recommendation: For structured annotation and downstream applications, treat "CDH8-AS1" as insufficiently defined or not a current valid therapeutic target. If you need information about CHD8 or CDH8 (cadherin 8 protein), please clarify for detailed, accurate coverage.

Beyond the preview

Go deeper on CDH8 antisense RNA 1 (CDH8-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CDH8 antisense RNA 1 (CDH8-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call